良性骨腫瘍の治療における生物活性ガラスの臨床的および放射線学的アウトカム:64例の遡及的研究
Sevan Sivacioglu1, Melih Civan2, Onur Cetin3
1Private Clinic, Istanbul-Türkiye.
まとめ
生物活性ガラス (BG) は良性骨腫瘍を効果的に治療し,機能の改善と高い治癒率を示しています. この骨移植の代替品は 特に小児の患者に 最小限の合併症を伴う 安全な代替品です
科学分野:
- 整形 術
- バイオマテリアル科学
- 腫瘍学
背景:
- 骨の良性腫瘍は,痛み,骨折の危険性,または機能的欠陥のためにしばしば外科的介入を必要とします.
- 骨移植はしばしば必要であり,特に小児の症例では自己移植が課題となる.
- 生物活性ガラス (BG) は従来の骨移植に代わる 有望な合成ガラスです
研究 の 目的:
- 良性骨腫瘍の治療における生物活性ガラス (BG) の臨床的および放射線学的有効性を評価する.
- BG骨移植に関連する機能的結果と合併症率を評価する.
- 良性骨の欠陥の管理における骨移植の代替品としてのBGの適性を決定する.
主な方法:
- 64人の患者 (71件の処置) が,良性骨腫瘍に対するキュレタージとBG移植を受けた後の分析 (2004年から2023年).
- 筋肉骨腫瘍学会 (MSTS) のスコアを用いて測定された機能的アウトカム.
- 放射線による治癒は,ニーアーの分類によって評価される.
主要な成果:
- 治療後のMSTSスコア (17. 6から28. 1,p<0. 05) の有意な改善
- 労働組合の割合は,NERの分類に基づいて高かった.
- 合併症は再発 (5例),骨折 (9例),表面感染 (4例),深部感染や物質関連の有害事象はなかった.
結論:
- 生物活性ガラス (BG) は,良性骨の欠陥に対する骨の代替品としての安全性と有効性を実証しています.
- BGはオート移植の有効な代替品であり,特に移植の選択肢が限られている小児の患者には有効です.
- BGの骨伝導性,感染抵抗性,および骨の再構築に適合する性質は,骨の欠陥管理におけるその使用を支持する.
関連する概念動画
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:27Fractures: Bone Repair
Treatment for a fracture is based on the type of break, the bone affected, and the patient's age.
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the procedure...
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the procedure...
01:29Bone Disorders
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...